American Heart of Poland Group (AHP) was established in the year 2000 by the team of outstanding physicians from both Poland and the United States.
At present, the Group comprises of 30 medical centres and Ustron Health Resort, what makes American Heart of Poland the biggest European network with such a complex offer for patients suffering from cardiovascular diseases: from the prophylaxis and diagnostics, through highly-innovative cardiology, cardiac surgery and vascular surgery procedures, to inidividually tailored rehabilitation allowing the patient to achieve full and lasting recovery.
Rehabilitation is carried out in the Ustron Health Resort – one of the biggest health resorts in Europe. In the last 3 years, the American Heart of Poland has invested approximately 60 million PLN (Polish Zlotys) in the Resort, focusing on the quality of treatments offered and standard of the accommodation.
American Heart of Poland Group does not only focus on diagnostics, treatment and rehabilitation in patients suffering from heart and cilculatory system diseases, but also carries out research activity. The Centre for Cardiovascular Research and Development (CCRD) constitues an important part of the Group. By implementing modern solutions into everyday clinical practice, the CCRD improves cardiovascular treatment outcomes in Polish hospitals. The most recent projects carried out by the CCRDinclude:
- hybrid coronary revascularization carried out in patients with advanced multivessel coronary artery disease;
- percutaneous mitral annuloplasty for the alleviation of heart failure symptoms in patients with mitral valve reguritation;
- aortic valve replacement with the use of a modern, self-expanding, equine pericardial aortic bioprosthesis – 3f ® Aortic Bioprosthesis by Medtronic;
- clinical trial assessing the use of the first Polish drug coated balloon (PAX®, Balton company) in the treatment of coronary and peripheral artery diseases.
Implantation of a first Polish hybrid carotid stent „MER” with the use of distal cerebral protection device „ROBIN”, in the patient with advanced cardiovascular disease, was one of the CCDR researchers' latest major achievements. The stents are manufactured by the Balton company and have been CE Mark certified .
INFORMATION FOR THE PATIENT AND PARTIES INTERESTED in connection with the entry into force of 25/05/2018
of the EU Regulation on the Protection of Personal Data (GDPR)